Semi-Annual Statement Of Income And Retained Earnings

COSMOS Pharmaceutical Corporation - Filing #7360741

Concept 2023-06-01 to
2023-11-30
2022-06-01 to
2022-11-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
15,836,000,000 JPY
15,385,000,000 JPY
Non-operating income
Non-operating income
1,846,000,000 JPY
1,817,000,000 JPY
Non-operating expenses
Non-operating expenses
337,000,000 JPY
302,000,000 JPY
Ordinary profit (loss)
17,346,000,000 JPY
16,900,000,000 JPY
Extraordinary income
Extraordinary income
JPY
26,000,000 JPY
Extraordinary losses
Extraordinary losses
132,000,000 JPY
161,000,000 JPY
Profit (loss) before income taxes
17,213,000,000 JPY
16,764,000,000 JPY
Profit (loss)
11,587,000,000 JPY
11,299,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.